Revvity Inc (RVTY) PT Raised to $130 at Jefferies

Jefferies analyst Tycho Peterson raised the price target on Revvity Inc (NYSE: RVTY) to $130.00 (from $120.00) while maintaining a Hold rating.

The analyst comments "Revenues were as expected given the preannouncement, with +5% EPS upside aided by buybacks (+2%). Looking ahead, '25 guidance bracketed the Street at high end for core growth (+3-5%) and EPS ($4.90-5.00) and assumes no improvement in trends, which may prove conservative. That said, while potential upside to biopharma demand (via reagents) is intriguing, we expect investors to stay focused on bioproduction and signs of an instrument recovery. Reiterate Hold."

You May Also Be Interested In

• Berenberg Upgrades Accelleron Industries AG (ACLN:SW) to Buy
• Nomura/Instinet Downgrades Indraprastha Gas Ltd. (IGL:IN) to Neutral
• Jefferies Downgrades BSE Limited (BSE:IN) to Underperform